VICTORIA ATCHISON: Open Payments
NPI 1851801351 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 39 payments from 22 companies in 2025. Trend: 2023 $435 · 2024 $1,406 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 8 | $195 |
| Geron Corporation | 1 | $116 |
| Merck Sharp & Dohme LLC | 5 | $102 |
| Janssen Biotech, Inc. | 3 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Syndax Pharmaceuticals, Inc. | 2 | $47 |
| Genentech USA, Inc. | 2 | $41 |
| SOBI, INC | 1 | $35 |
| GENZYME CORPORATION | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $32 |
Products named: DATROWAY, RYTELO, KISQALI, KEYTRUDA, Enhertu, CARVYKTI, Gamifant, AYVAKIT.
Industry payments across DE — which companies pay providers there.
